SMTL ID : 7ltz.1

Bruton's tyrosine kinase in complex with compound 51

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.53 Å

Oligo State

monomer

Ligands

1 x YDA: 1-~{tert}-butyl-~{N}-[(5~{R})-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-2-(oxetan-3-yl)-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,2,3-triazole-4-carboxamide(Non-covalent)

YDA.1: 20 residues within 4Å: Chain A: L.16, G.17, T.18, G.19, F.21, V.24, A.36, K.38, E.83, Y.84, M.85, A.86, G.88, D.129, L.136, D.147, L.150, V.154, Y.159 Ligands: DTT.2 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.21, A:V.24, A:V.24, A:A.36, A:L.136, A:D.147, A:V.154 Hydrogen bonds: A:K.38, A:M.85, A:M.85 Water bridges: A:Q.20

1 x DTT: 2,3-DIHYDROXY-1,4-DITHIOBUTANE(Non-covalent)

DTT.2: 5 residues within 4Å: Chain A: C.89, L.91, N.92, R.133 Ligands: YDA.1 No protein-ligand interaction detected (PLIP)

2 x ACT: ACETATE ION(Non-functional Binders)

ACT.3: 1 residues within 4Å: Chain A: F.12 1 PLIP interactions: 1 interactions with chain A Water bridges: A:F.12 ACT.4: 4 residues within 4Å: Chain A: S.257, L.260, D.261, D.264 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.260 Water bridges: A:S.257, A:D.264

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hopkins, B.T. et al., Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis. J.Med.Chem. (2022)

Release Date

2022-01-12

Peptides

Isoform BTK-C of Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Isoform BTK-C of Tyrosine-protein kinase BTK

Related Entries With Identical Sequence